Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0OLXNM
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
POZ-polymer ADCs
|
|||||
| Synonyms |
POZ-polymer ADCs (Serina Therapeutics); POZ polymer ADCs; SER-214
Click to Show/Hide
|
|||||
| Organization |
Serina Therapeutics, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
B-cell antigen receptor complex-associated protein beta chain (CD79B)
|
Antigen Info | ||||
| Payload Name |
Rotigotine
|
Payload Info | ||||
| Therapeutic Target |
D(1A) dopamine receptor (DRD1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
POZ drug delivery platform.
|
|||||
| Combination Type |
POZ conjugate of rotigotine
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.